Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:
NCT02342977 is a phase 2 interventional trial sponsored by Indiana University. As of 21 Nov 2026, it was withdrawn. It studies Lacosamide and Placebo in Avascular Necrosis, Osteoarthritis and 1 more condition. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2014 and a primary completion date of 31 Aug 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02342977 |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional trial |
| Lead sponsor | Indiana University |
| Enrollment | 0 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Avascular Necrosis, Osteoarthritis and Rheumatoid Arthritis |
| Drugs | Lacosamide and Placebo |
| Start | 30 Nov 2014 |
| Primary completion | 31 Aug 2016 |
| Study completion | 31 Aug 2016 |
| Last update posted | 26 Aug 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Bryan M Sakamoto, M.D., PhD
Richard L. Roudebush VA Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Richard L. Roudebush Veterans Affairs Medical Center
Indianapolis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT02342977
Each answer restates registry values shown on this page.
What is NCT02342977?
NCT02342977 is a phase 2 interventional trial sponsored by Indiana University. It studies Lacosamide and Placebo in Avascular Necrosis, Osteoarthritis and 1 more condition.
Who leads NCT02342977?
The registry names Bryan M Sakamoto, M.D., PhD (principal investigator, Richard L. Roudebush VA Medical Center) as the overall official.
Where does NCT02342977 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT02342977 study?
The registered drug and biological interventions are Lacosamide and Placebo.
When did NCT02342977 end?
The registry lists a primary completion date of 31 Aug 2016 and a study completion date of 31 Aug 2016. The sponsor last updated the record on 26 Aug 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.